Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
14.20
-0.29 (-2.00%)
Dec 5, 2025, 4:00 PM EST - Market closed
Amylyx Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Net Income | -149.28 | -301.74 | 49.27 | -198.38 | -87.93 | -42.28 | Upgrade
|
| Depreciation & Amortization | 0.58 | 0.9 | 1.09 | 0.49 | 0.05 | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.96 | 0.96 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -6.26 | -9.86 | -9.94 | -2.06 | 0.12 | - | Upgrade
|
| Stock-Based Compensation | 28 | 33.04 | 37.16 | 21.71 | 3.14 | 0.24 | Upgrade
|
| Other Operating Activities | -0.56 | 154.88 | - | - | 5.23 | 2.74 | Upgrade
|
| Change in Accounts Receivable | 1.6 | 39.6 | -24.74 | -15.31 | - | - | Upgrade
|
| Change in Inventory | - | -9.25 | -73.13 | -9.77 | - | - | Upgrade
|
| Change in Accounts Payable | 1.78 | -19.1 | 15.88 | 1.85 | 0.67 | 1.42 | Upgrade
|
| Change in Other Net Operating Assets | -31.25 | -57.08 | 16.33 | 21.58 | 3.93 | 1.18 | Upgrade
|
| Operating Cash Flow | -154.45 | -167.65 | 11.92 | -179.87 | -74.8 | -36.7 | Upgrade
|
| Capital Expenditures | -36.28 | -36.36 | -1.24 | -2.53 | -0.35 | -0.15 | Upgrade
|
| Investment in Securities | 49.62 | 112.01 | 93.29 | -236.46 | -46.05 | - | Upgrade
|
| Investing Cash Flow | 49.55 | 75.65 | 92.05 | -238.99 | -46.41 | -0.15 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 26.16 | 16.82 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -0.26 | - | Upgrade
|
| Net Debt Issued (Repaid) | 256.69 | - | - | - | 25.9 | 16.82 | Upgrade
|
| Issuance of Common Stock | 3.85 | 2.13 | 6.99 | 434.64 | 0.34 | 0.05 | Upgrade
|
| Repurchase of Common Stock | -3.19 | -1.78 | -3.32 | - | - | - | Upgrade
|
| Other Financing Activities | - | - | -0.14 | -2.85 | -2.73 | - | Upgrade
|
| Financing Cash Flow | 257.35 | 0.35 | 3.54 | 431.79 | 158.51 | 46.82 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.43 | -0.44 | 0.16 | -0.07 | 0.01 | - | Upgrade
|
| Net Cash Flow | 152.88 | -92.08 | 107.68 | 12.87 | 37.31 | 9.98 | Upgrade
|
| Free Cash Flow | -190.72 | -204.01 | 10.68 | -182.4 | -75.15 | -36.85 | Upgrade
|
| Free Cash Flow Margin | - | -233.50% | 2.80% | -820.50% | -26369.12% | -5668.92% | Upgrade
|
| Free Cash Flow Per Share | -2.27 | -2.99 | 0.15 | -3.12 | -11.41 | -6.06 | Upgrade
|
| Cash Income Tax Paid | 0.71 | 0.71 | 6.39 | 0.03 | - | - | Upgrade
|
| Levered Free Cash Flow | -118.12 | -157.37 | 38.36 | -105.35 | -46.85 | -23.54 | Upgrade
|
| Unlevered Free Cash Flow | -118.12 | -157.37 | 38.36 | -105.35 | -46.85 | -22.11 | Upgrade
|
| Change in Working Capital | -27.88 | -45.83 | -65.66 | -1.64 | 4.6 | 2.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.